AU2002213806A1 - Dna sequences, which code for optimised eukaryotic hpv 16-l1 and hpv 16-l2 - Google Patents

Dna sequences, which code for optimised eukaryotic hpv 16-l1 and hpv 16-l2

Info

Publication number
AU2002213806A1
AU2002213806A1 AU2002213806A AU1380602A AU2002213806A1 AU 2002213806 A1 AU2002213806 A1 AU 2002213806A1 AU 2002213806 A AU2002213806 A AU 2002213806A AU 1380602 A AU1380602 A AU 1380602A AU 2002213806 A1 AU2002213806 A1 AU 2002213806A1
Authority
AU
Australia
Prior art keywords
hpv
optimised
eukaryotic
code
dna sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002213806A
Inventor
Sophia Biemelt
Jurgen Kleinschmidt
Christoph Leder
Martin Muller
Uwe Sonnewald
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Deutsches Krebsforschungszentrum DKFZ
Institut fuer Pflanzengenetik und Kulturpflanzenforschung
Original Assignee
Deutsches Krebsforschungszentrum DKFZ
Institut fuer Pflanzengenetik und Kulturpflanzenforschung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforschungszentrum DKFZ, Institut fuer Pflanzengenetik und Kulturpflanzenforschung filed Critical Deutsches Krebsforschungszentrum DKFZ
Publication of AU2002213806A1 publication Critical patent/AU2002213806A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
AU2002213806A 2000-11-09 2001-09-19 Dna sequences, which code for optimised eukaryotic hpv 16-l1 and hpv 16-l2 Abandoned AU2002213806A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10055545A DE10055545A1 (en) 2000-11-09 2000-11-09 HPV 16-L1 and HPV 16-L2 encoding DNA sequences optimized for expression in eukaryotes
DE10055545.4 2000-11-09
PCT/DE2001/003618 WO2002038769A2 (en) 2000-11-09 2001-09-19 Dna sequences, which code for optimised eukaryotic hpv 16-l1 and hpv 16-l2

Publications (1)

Publication Number Publication Date
AU2002213806A1 true AU2002213806A1 (en) 2002-05-21

Family

ID=7662695

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002213806A Abandoned AU2002213806A1 (en) 2000-11-09 2001-09-19 Dna sequences, which code for optimised eukaryotic hpv 16-l1 and hpv 16-l2

Country Status (3)

Country Link
AU (1) AU2002213806A1 (en)
DE (1) DE10055545A1 (en)
WO (1) WO2002038769A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2004003021A0 (en) * 2001-08-31 2004-06-30 Univ Cape Town Vectors, constructs and transgenic plants for HPV-11 and HPV-16 L1 capsid protein.
KR20060003903A (en) * 2003-05-05 2006-01-11 이스티투토 디 리세르쉐 디 비올로지아 몰레콜라레 피. 안젤레티에스.피.에이. Synthetic gene encoding human carcinoembryonic antigen and uses thereof
EP1716173B8 (en) 2004-02-11 2012-06-27 Istituto di Ricerche di Biologia Molecolare P. Angeletti S.R.L. Carcinoembryonic antigen fusion protein and uses thereof
US8101342B2 (en) 2006-08-28 2012-01-24 Sungkyunkwan University Foundation For Corporate Collaboration DNA vaccine for treating or preventing cervical cancer comprising a gene encoding HPV protein
MY182347A (en) * 2007-11-23 2021-01-20 Shanghai Zerun Biotechnology Co Ltd Genes encoding major capsid protein l1 of human papilloma virus and use of the same
BR102019025802A2 (en) 2019-12-05 2022-01-18 Instituto Butantan PROCESS OF PRODUCTION OF A PROPHYLATIC AND THERAPEUTIC DNA IMMUNOLOGICAL COMPOSITION AGAINST HPV AND VIRUS-ASSOCIATED CANCER, HYBRID PROTEIN, EXPRESSION VECTOR, IMMUNOLOGICAL COMPOSITION AND THEIR USES

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994012632A1 (en) * 1992-11-27 1994-06-09 University College London Improvements in nucleic acid synthesis by pcr
US6114148C1 (en) * 1996-09-20 2012-05-01 Gen Hospital Corp High level expression of proteins
CA2296067C (en) * 1997-07-09 2008-10-07 The University Of Queensland Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue
US6228368B1 (en) * 1997-10-06 2001-05-08 Loyola University Of Chicago Papilloma virus capsomere formulations and method of use
CA2229955C (en) * 1998-02-20 2003-12-09 Medigene Gmbh Papilloma virus capsomere vaccine formulations and methods of use
DK1108035T3 (en) * 1998-09-04 2007-09-24 Sanofi Pasteur Ltd Treatment of cervical cancer
PT1212358E (en) * 1999-08-25 2005-04-29 Merck & Co Inc SYNTHETIC GENES OF HUMAN PAPILOMAVIRUS

Also Published As

Publication number Publication date
DE10055545A1 (en) 2002-07-25
WO2002038769A3 (en) 2003-01-09
WO2002038769A2 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
AU2002336367A1 (en) Adamts13 genes and proteins and variants, and uses thereof
AU2002214081A1 (en) Listeria inocua, genome and applications
AU2001285844A1 (en) Nucleotide sequences which code for the meth gene
AUPQ659800A0 (en) Genetic sequences and uses therefor
AU2002213806A1 (en) Dna sequences, which code for optimised eukaryotic hpv 16-l1 and hpv 16-l2
AU2001242625A1 (en) Gene sequence
AU2001294833A1 (en) Chlamydia pmp proteins, gene sequences and uses thereof
AU2001265096A1 (en) Short-root gene, promoter, and uses thereof
AU2001264247A1 (en) GASC1 gene
AU2001293821A1 (en) Nucleotide sequences which code for the dead gene
AU2001285878A1 (en) Nucleotide sequences which code for the roda gene
AU2001295456A1 (en) Nucleotide sequences which code for the gora gene
AU2002215389A1 (en) Optimized messenger rna
AU2002212232A1 (en) Nucleotide sequences which code for the dps gene
AU2002212155A1 (en) Nucleotide sequences which code for the ppgk gene
AU2001291658A1 (en) Nucleotide sequences which code for the ccpa2 gene
AU2001285743A1 (en) Adipose-related gene
AU2001293730A1 (en) Nucleotide sequences which code for the chra gene
AU2001287630A1 (en) Nucleotide sequences which code for the mete gene
AU2001282084A1 (en) Nucleotide sequences which code for the sigh gene
AU2001295580A1 (en) Nucleotide sequences which code for the dep67 protein
AU2001291729A1 (en) Nucleotide sequences which code for the cobw gene
AU2001285947A1 (en) Nucleotide sequences which code for the ndka gene
AU2001272533A1 (en) Nucleotide sequence which codes for the alr gene
AU2002307963A1 (en) Genetic typing